Back to Search
Start Over
Systemic Mineralocorticoid Antagonists in the Treatment of Central Serous Chorioretinopathy.
- Source :
-
Seminars in Ophthalmology . 2017, Vol. 32 Issue 1, p36-42. 7p. - Publication Year :
- 2017
-
Abstract
- Central serous chorioretinopathy (CSCR) is a challenging disease characterized by subretinal serous fluid accumulation. The complex pathogenesis is still not fully understood, but is thought to be multifactorial and involves exogenous and endogenous factors affecting the choroid and retinal pigment epithelium. The involvement of corticosteroids is undisputed, while the contribution of mineralocorticoid pathways is under investigation. This review addresses the proposed pathogenesis models and the evidence for systemic treatment of CSCR with mineralocorticoid antagonists. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 08820538
- Volume :
- 32
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- Seminars in Ophthalmology
- Publication Type :
- Academic Journal
- Accession number :
- 120599674
- Full Text :
- https://doi.org/10.1080/08820538.2016.1228418